Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivity and pain in hands and feet is the major dose-limiting toxicity of many chemotherapeutics. At present, there are no FDA-approved treatments for CIPN. The anti-diabetic drug metformin is the most widely used prescription drug in the world and improves glycemic control in diabetes patients. There is some evidence that metformin enhances the efficacy of cancer treatment. The aim of this study was to test the hypothesis that metformin protects against chemotherapy-induced neuropathic pain and sensory deficits. Mice were treated with cisplatin together with metformin or saline. Cisplatin induced increased sensitivity to mechanical stimulation (mechanica...
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies show it...
Peripheral neuropathy is one of the major co-morbidities associated with diabetes mellitus. Neurotox...
[[abstract]]Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer trea...
<div><p>Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivi...
<p>A). Mice (n = 6–10/group) were treated with cisplatin and metformin as described in <a href="http...
Abstract Metformin is a hypoglycemic drug widely used in the treatment of type 2 diabetes. It has be...
Cisplatin often causes loss of touch sensitivity in the hands and feet of cancer patients as well as...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a major dose-limiting side effect of several an...
<p>Mice (n = 4–6 per group) were treated with cisplatin and metformin as in <a href="http://www.plo...
Chemotherapy drugs have neurotoxicity associated with treatment , which can become a dose-limiting ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment. It is...
Introduction: Metformin is currently first line therapy for type 2 diabetes (T2D). The mechanism of ...
Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating condition that affects up to 70%...
Despite the large amount of human and experimental studies no effective (prophylactic) treatment exi...
Metformin, a well-known antidiabetic drug, has recently been proposed to promote neurogenesis and to...
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies show it...
Peripheral neuropathy is one of the major co-morbidities associated with diabetes mellitus. Neurotox...
[[abstract]]Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer trea...
<div><p>Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivi...
<p>A). Mice (n = 6–10/group) were treated with cisplatin and metformin as described in <a href="http...
Abstract Metformin is a hypoglycemic drug widely used in the treatment of type 2 diabetes. It has be...
Cisplatin often causes loss of touch sensitivity in the hands and feet of cancer patients as well as...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a major dose-limiting side effect of several an...
<p>Mice (n = 4–6 per group) were treated with cisplatin and metformin as in <a href="http://www.plo...
Chemotherapy drugs have neurotoxicity associated with treatment , which can become a dose-limiting ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment. It is...
Introduction: Metformin is currently first line therapy for type 2 diabetes (T2D). The mechanism of ...
Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating condition that affects up to 70%...
Despite the large amount of human and experimental studies no effective (prophylactic) treatment exi...
Metformin, a well-known antidiabetic drug, has recently been proposed to promote neurogenesis and to...
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies show it...
Peripheral neuropathy is one of the major co-morbidities associated with diabetes mellitus. Neurotox...
[[abstract]]Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer trea...